AT-808

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAT-808
Drug Alias Namefrataxin gene therapy (Astellas)AAV8-PGK-hFXNAT-808
ClassificationBiologics
Mechanisms of ActionFrataxin Gene transference
TargetsFrataxin, mitochondrial
Therapy Area/IndicationsFriedreich Ataxia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsFriedreich Ataxia

Other Information

ATC CodeN/A
Related LinksN/A